Home/Pipeline/Alosita

Alosita

Type 2 diabetes

CommercialActive

Key Facts

Indication

Type 2 diabetes

Phase

Commercial

Status

Active

Company

About Saffron Pharma

A leading Pakistani generic drug manufacturer leveraging proprietary delivery technologies across multiple therapeutic areas.

View full company profile

Therapeutic Areas

Infectious Diseases Endocrinology Gastroenterology Dermatology Cardiovascular Immunology

Other Type 2 diabetes Drugs

Drug	Company	Phase	Status
Diabetes Management Gel	Gelteq Limited	Formulation Development	Active
Tolimidone	Biodexa Pharmaceuticals	Phase 2	Acquired Asset
Generic Semaglutide Injection (Obeda)	Dr. Reddy's Laboratories	Approved	Launched in India
BioChaperone® Lispro	Adocia	Phase 3	Active
BioChaperone® Combo (Insulin Glargine / Lixisenatide)	Adocia	Phase 2	Active
Metformin API	USV Biologics Division	Commercial	Active
Empagliflozin	Azico Biophore	Commercial	Active
Sitagliptin Intermediate	AR Life Science	Commercial	Active
AJN003 (LuCI™)	AltrixBio	Pre-clinical	Advancing to Phase 1 (planned 2026)
Sitagliptin Phosphate Polymorph	Morepen Laboratories	Pre‑clinical	Active
Hepatic Denervation for Type 2 Diabetes	Metavention	Feasibility	Active
MVD-1 (SANA)	Eolo Pharma	Discovery	Active